Jste novinář?

Seznamte se se společností ALK

Pokud máte jakékoli dotazy, kontaktujte tým pro vztahy s médii v centrále společnosti ALK nebo některou z našich globálních kanceláří.

The press releases in this press room contains information that is of general news value for the press, and available for journalists or media with a view to journalistic assessment and preparation before publication.

Zprávy

  • Post date
    08/27/2024
    Report on transactions with ALK-Abelló A/S B-shares and associated securities by managerial staff
  • Post date
    08/22/2024
    ALK upgrades its full-year revenue and earnings outlook
  • Post date
    08/22/2024
    Six-month interim report (Q2) 2024
  • Post date
    08/14/2024
    Invitation to the presentation of ALK’s results for the first six months (Q2) 2024 on Friday 23 August 2024
  • Post date
    06/21/2024
    ALK provides update on regulatory process for the house dust mite allergy tablet in China
  • Post date
    06/21/2024
    ALK upgrades its full-year revenue and earnings outlook
  • Post date
    06/03/2024
    ALK presents positive phase 3 paediatric trial data offering new hope for children with respiratory allergies
  • Post date
    06/03/2024
    ALK launches new growth strategy and 2028 financial ambitions
  • Post date
    05/30/2024
    ALK’s European registration application for ITULAZAX® for paediatric indication accepted for review

Mediální vztahy

Vztahy s investory

Per Plotnikof

Viceprezident,

Firemní komunikace

Vztahy s investory a strategické plánování

Telefon: +45 2261 2525

E-mail: PPIDK@alk.net

Vztahy s médii

Tým pro vztahy s médii společnosti ALK vždy uvítá kontakt s novináři.
Steen Riisgaard, CEO
Production facilities, Hørsholm
Image
Media Img 3
Production facilities, Hørsholm
Image
Media Img 4
Production facilities, Hørsholm
Image
Media Img 5
Production facilities, Hørsholm
Image
Media Img 6
ALK HQ, Hørsholm
Last updated: 2022.11.17